A detailed history of Cipher Capital LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Cipher Capital LP holds 7,335 shares of ABBV stock, worth $1.3 Million. This represents 0.63% of its overall portfolio holdings.

Number of Shares
7,335
Previous 22,833 67.88%
Holding current value
$1.3 Million
Previous $3.54 Million 62.27%
% of portfolio
0.63%
Previous 1.16%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $2.48 Million - $2.82 Million
-15,498 Reduced 67.88%
7,335 $1.34 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $1.73 Million - $1.95 Million
12,561 Added 122.28%
22,833 $3.54 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $564,551 - $653,550
4,226 Added 69.9%
10,272 $1.53 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $801,155 - $996,985
6,046 New
6,046 $814,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cipher Capital LP Portfolio

Follow Cipher Capital LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cipher Capital LP, based on Form 13F filings with the SEC.

News

Stay updated on Cipher Capital LP with notifications on news.